このアイテムのアクセス数: 92

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
20013078.2019.1696517.pdf1.57 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorMatsumoto, Akihiroen
dc.contributor.authorTakahashi, Yukien
dc.contributor.authorChang, Hsin‐Yien
dc.contributor.authorWu, Yi‐Wenen
dc.contributor.authorYamamoto, Akien
dc.contributor.authorIshihama, Yasushien
dc.contributor.authorTakakura, Yoshinobuen
dc.contributor.alternative松本, 明宏ja
dc.contributor.alternative高橋, 有己ja
dc.contributor.alternative張, 心儀ja
dc.contributor.alternative山本, 晶ja
dc.contributor.alternative石濱, 泰ja
dc.contributor.alternative髙倉, 喜信ja
dc.date.accessioned2023-03-10T04:40:48Z-
dc.date.available2023-03-10T04:40:48Z-
dc.date.issued2020-09-
dc.identifier.urihttp://hdl.handle.net/2433/279639-
dc.description.abstractSmall extracellular vesicles (sEVs) are important mediators of cell–cell communication with respect to diverse physiological processes. To further understand their physiological roles, understanding blood sEV homoeostasis in a quantitative manner is desired. In this study, we propose novel kinetic approaches to estimate the secretion and clearance of mouse plasma–derived sEVs (MP-sEVs) based on the hypothesis that blood sEV concentrations are determined by a balance between the secretion and clearance of sEVs. Using our specific and sensitive sEV labelling technology, we succeeded in analysing MP-sEV clearance from the blood after intravenous administration into mice. This revealed the rapid disappearance of MP-sEVs with a half-life of approximately 7 min. Moreover, the plasma sEV secretion rate, which is presently impossible to directly evaluate, was calculated as 18 μg/min in mice based on pharmacokinetic (PK) analysis. Next, macrophage-depleted mice were prepared as a model of disrupted sEV homoeostasis with retarded sEV clearance. MP-sEV concentrations were increased in macrophage-depleted mice, which probably reflected a shift in the balance of secretion and clearance. Moreover, the increased MP-sEV concentration in macrophage-depleted mice was successfully simulated using calculated clearance rate constant, secretion rate constant and volume of distribution, suggesting the validity of our PK approaches. These results demonstrate that blood sEV concentration homoeostasis can be explained by the dynamics of rapid secretion/clearance.en
dc.language.isoeng-
dc.publisherTaylor & Francis Groupen
dc.rights© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.en
dc.rightsThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/-
dc.subjectSmall extracellular vesicle (sEV)en
dc.subjectpharmacokinetic (PK)en
dc.subjectsecretionen
dc.subjectclearanceen
dc.titleBlood concentrations of small extracellular vesicles are determined by a balance between abundant secretion and rapid clearanceen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleJournal of Extracellular Vesiclesen
dc.identifier.volume9-
dc.identifier.issue1-
dc.relation.doi10.1080/20013078.2019.1696517-
dc.textversionpublisher-
dc.identifier.artnum1696517-
dc.identifier.pmid31807238-
dcterms.accessRightsopen access-
datacite.awardNumber17K19390-
datacite.awardNumber18H02562-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-17K19390/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18H02562/-
dc.identifier.eissn2001-3078-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitle血中滞留性の高い細胞外小胞画分の探索・同定とその生理機能の解明ja
jpcoar.awardTitle免疫制御分子搭載エキソソームを利用したin vivo遺伝子治療法の開発ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons